GEN Exclusives

More »

GEN News Highlights

Back to Item »

Alkem Gains Rights to Karo Bio’s Phase III Dyslipidemia Drug in India

Karo says deal will cut its late-stage development costs for eprotirome by SEK 100 million.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?